Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHome Gp 43 Regulatory News (93LF)

Share Price Information for Home Gp 43 (93LF)

Share Price is delayed by 15 minutes
Get Live Data
69.8115    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
93LF Live PriceLast checked at - London Stock Exchange

Intraday Home Gp 43 Share Chart

Directorate Change

4 May 2022 09:05

RNS Number : 2653K
Home Group Ld
04 May 2022
 

New Executive appointments announced

at Home Group

 

One of the UK's largest housing associations has announced the appointment of two executive directors as it sets out on a new five-year strategy.

 

Home Group, one of the country's largest providers of housing, health and care, has appointed a new Chief Financial Officer and new Executive Director of Development.

 

Both appointments are internal and ensures a smooth transition as the group builds on the success of its last strategy.

 

Helen Brindley has been appointed as the new Chief Financial Officer and will take up the role in late summer. She is currently Director of Finance at the North-East headquartered organisation.

 

She joined Home Group in 2015 as Director of Risk and Assurance, moving to Director of Finance in 2018. Previous to that she was at PwC.

 

Helen will take over the role from current CFO John Hudson.

 

Home Group has also recruited from within for the role of Executive Director of Development.

 

Will Gardner, who was previously Director of Development, moves into the executive team. He takes up the role immediately.

 

Will joined Home Group as Head of Development in the southern region almost seven years ago. He took up the Director of Development role in 2017. 

 

Mark Henderson, chief executive of Home Group, said: "One of the key components in our new five-year strategy is about 'growing our own'. So, I couldn't be more delighted to welcome my colleagues Helen and Will to the executive team.

 

"They were integral to the successful delivery of our last five-year plan, so to have them on board as executive members as we begin on our new strategic journey is reassuring indeed.

 

"We have ambitious plans for the next five years and with the energy, expertise and leadership Will and Helen bring to the executive team it puts us in an even stronger position to achieve them."

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUSRWRUSUVRRR
Date   Source Headline
3rd Jun 202612:09 pmRNSDirectorate change
7th Jan 20262:07 pmRNSDirectorate change
2nd Dec 20252:10 pmRNSTrading Statement
19th Aug 202510:33 amRNSTrading Statement
28th Apr 202511:39 amRNSInvestor update
5th Dec 20243:07 pmRNSTrading Statement
23rd Aug 202412:09 pmRNSTrading update
26th Apr 20243:10 pmRNSInvestor update
7th Dec 20231:46 pmRNSTrading Statement
18th Sep 202312:03 pmRNSTrading Statement
25th Apr 20239:40 amRNSInvestor update
21st Dec 20221:23 pmRNSTrading Statement
26th Oct 20222:39 pmRNSDirectorate Change
29th Jul 202210:58 amRNSTrading Statement
4th May 20229:05 amRNSDirectorate Change
17th Feb 202211:14 amRNSDirectorate Change
17th Dec 202111:08 amRNSTrading update
1st Sep 20219:11 amRNSFinal Results
9th Sep 202011:48 amRNSFinal Results
9th Jun 20203:54 pmRNSDirectorate Change
5th May 20209:56 amRNSAnnouncement of Investor Call
2nd Sep 20194:53 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.